NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,070,293 | -46.5% | 190,111 | +37.4% | 0.00% | -50.0% |
| Q2 2023 | $5,742,314 | +4.8% | 138,369 | +51.8% | 0.00% | +100.0% |
| Q1 2023 | $5,480,198 | +16.7% | 91,124 | +42.3% | 0.00% | 0.0% |
| Q4 2022 | $4,696,233 | +133.2% | 64,025 | +141.6% | 0.00% | – |
| Q3 2022 | $2,014,000 | +23.2% | 26,503 | +12.6% | 0.00% | – |
| Q2 2022 | $1,635,000 | -22.5% | 23,535 | -7.6% | 0.00% | – |
| Q1 2022 | $2,111,000 | -0.5% | 25,480 | -9.8% | 0.00% | – |
| Q4 2021 | $2,121,000 | -30.5% | 28,236 | +7.5% | 0.00% | – |
| Q3 2021 | $3,052,000 | -84.4% | 26,267 | -70.2% | 0.00% | -100.0% |
| Q2 2021 | $19,564,000 | +167.2% | 88,198 | +59.3% | 0.01% | +250.0% |
| Q1 2021 | $7,321,000 | -40.0% | 55,383 | -21.4% | 0.00% | -50.0% |
| Q4 2020 | $12,194,000 | +161.7% | 70,469 | +68.3% | 0.00% | +100.0% |
| Q3 2020 | $4,660,000 | +254.4% | 41,862 | +88.7% | 0.00% | – |
| Q2 2020 | $1,315,000 | -74.8% | 22,181 | -71.4% | 0.00% | -100.0% |
| Q1 2020 | $5,227,000 | -63.1% | 77,616 | -53.9% | 0.00% | -60.0% |
| Q4 2019 | $14,183,000 | +71.8% | 168,318 | +52.5% | 0.01% | +66.7% |
| Q3 2019 | $8,256,000 | +47.1% | 110,401 | +24.4% | 0.00% | +50.0% |
| Q2 2019 | $5,612,000 | +129.7% | 88,748 | +75.0% | 0.00% | +100.0% |
| Q1 2019 | $2,443,000 | +3492.6% | 50,703 | +2401.4% | 0.00% | – |
| Q4 2018 | $68,000 | -98.2% | 2,027 | -97.1% | 0.00% | -100.0% |
| Q3 2018 | $3,723,000 | +54.0% | 71,040 | -8.0% | 0.00% | 0.0% |
| Q2 2018 | $2,418,000 | +1029.9% | 77,235 | +687.4% | 0.00% | – |
| Q1 2018 | $214,000 | +422.0% | 9,809 | +379.2% | 0.00% | – |
| Q4 2017 | $41,000 | -97.5% | 2,047 | -97.5% | 0.00% | -100.0% |
| Q3 2017 | $1,650,000 | +14.0% | 83,118 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $1,447,000 | +126.1% | 83,616 | +5.9% | 0.00% | – |
| Q1 2017 | $640,000 | +949.2% | 78,986 | +921.7% | 0.00% | – |
| Q4 2016 | $61,000 | +8.9% | 7,731 | +17.9% | 0.00% | – |
| Q3 2016 | $56,000 | -46.7% | 6,560 | -27.1% | 0.00% | – |
| Q2 2016 | $105,000 | +377.3% | 9,001 | +505.3% | 0.00% | – |
| Q1 2016 | $22,000 | -91.9% | 1,487 | -87.8% | 0.00% | – |
| Q4 2015 | $273,000 | – | 12,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |